pre-IPO PHARMA

COMPANY OVERVIEW

Innocoll Holdings Limited is a global specialty pharmaceutical company headquartered in Athlone, Ireland. Innocoll Holdings Limited and its subsidiary, Innocoll Pharmaceuticals Limited, are focused on the development and commercialization of pharmaceutical technologies to meet some of today’s most important healthcare challenges.


LOCATION

  • Newtown Square, PA, USA
  • Roscommon , , Ireland

  • THERAPEUTIC AREAS

  • Pain

  • WEBSITE

    https://www.innocoll.com


    CAREER WEBSITE

    https://innocoll.applicantstack.com/x/openings


    SOCIAL MEDIA


    INVESTORS

    gurnet-point-capital


    PRESS RELEASES


    Sep 26, 2022

    Innocoll and DURECT Announce U.S. launch of POSIMIR


    Jul 6, 2022

    Innocoll Announces Publication of Positive Results from Pivotal Clinical Trial of POSIMIR in Arthroscopic Subacromial Decompression


    Mar 28, 2022

    The Rosen Law Firm, P.A. Announces Proposed Securities Class Action Settlement on Behalf of Purchasers of Innocoll publicly traded securities


    Mar 2, 2022

    Innocoll Announces Positive Topline Results For XARACOLL (bupivacaine hydrochloride) implant in a Phase 3 Study to Support Expanded Use


    Jan 28, 2022

    Innocoll Announces Successful Completion of Debt Refinancing


    For More Press Releases


    Google Analytics Alternative